Ankind Ipo Subscription News Today

The bullish momentum in Mankind Pharma continued even after listing as the stock advanced another 9 per cent to Rs 1,414, extending the overall gains to about 31 per cent.

Mankind Pharma share price: Mankind Pharma shares debuted at a 20% premium on Dalal Street today. The stock of India’s fourth largest pharmaceutical company got listed at Rs 1,300 on BSE and NSE, against the issue price of Rs 1,080. Watch this Visual Story to know what investors should do with the stock.

The IPO of Mankind Pharma was open for subscription between April 25-27 in the price range of Rs 1,026-1,080 per share as the company raised 4,326 crore and issue was overall booked 15.32 times.

The IPO of Mankind Pharma, India’s fourth largest pharmaceutical company, received a strong response from the investors and was overall subscribed 15.32 times.

The IPO of Mankind Pharma was overall subscribed 15.32 times. The issue was open for subscription between April 25-27 in the price range of Rs 1,026-1,080 per share.

Mankind Pharma's issue of 28.04 crore equity shares fetched bids for 42.95 crore equity shares. It means shares worth Rs 3,028.45 crore attracted bids worth Rs 46,387 crore.

At the close of day two of bidding, the issue of Mankind Pharma was overall subscribed 87 per cent, with strong bidding from QIB and NII investors, whose quota sailed through.

A majority of the brokerage firms are positive on the issue and suggest investors subscribe to the issue on a long-term basis but some analysts have raised red flags over rich valuations and the complete OFS nature.

The IPO of Mankind Pharma was off the mark on Tuesday but the issue saw a muted response from the investors during the initial two hours of the book-building process.

A majority of the brokerage firms are positive on the issue and suggest investors subscribe to the issue on a long-term basis, but some analysts have raised red flags over rich valuations and complete OFS nature.